1. Home
  2. VIR vs XRAY Comparison

VIR vs XRAY Comparison

Compare VIR & XRAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$9.76

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

N/A

Current Price

$9.20

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIR
XRAY
Founded
2016
1899
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2019
2009

Fundamental Metrics

Financial Performance
Metric
VIR
XRAY
Price
$9.76
$9.20
Analyst Decision
Strong Buy
Hold
Analyst Count
8
17
Target Price
★ $23.38
$11.03
AVG Volume (30 Days)
1.8M
★ 5.0M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
★ 1.73%
EPS Growth
17.49
★ 33.04
EPS
N/A
★ 0.12
Revenue
★ $68,556,000.00
N/A
Revenue This Year
$305.75
N/A
Revenue Next Year
N/A
$0.64
P/E Ratio
★ N/A
$77.54
Revenue Growth
N/A
★ N/A
52 Week Low
$5.32
$8.14
52 Week High
$14.38
$14.76

Technical Indicators

Market Signals
Indicator
VIR
XRAY
Relative Strength Index (RSI) 39.70 46.21
Support Level $8.23 $8.23
Resistance Level $10.32 $10.71
Average True Range (ATR) 0.80 0.51
MACD -0.06 -0.02
Stochastic Oscillator 1.39 41.28

Price Performance

Historical Comparison
VIR
XRAY

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.

Share on Social Networks: